X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

期刊標題檢索 J EXP CLIN CANC 最新評論: Hello, do I need to upload the original data when submitting a paper? (2023-10-16)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH]您好,您是該頁面的第 197870 位訪客。

期刊簡介
期刊名稱JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
LetPub Score
7.7
51 ratings
Rate

Reputation
8.2

Influence
7.0

Speed
9.5

期刊簡稱J EXP CLIN CANC RES
ISSN1756-9966
h-index67
CiteScore
CiteScoreSJRSNIPCiteScore Rank
18.202.8061.770
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q123 / 404
Category: Medicine
Subcategory: Cancer Research
Q116 / 230

自引率 (2023-2024)1.80%自引率趨勢
掲載範囲
Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.
官方網站http://jeccr.biomedcentral.com
在線稿件提交https://www.editorialmanager.com/jecc/
開放訪問Yes
出版商BioMed Central
主題領域医学
出版國/地區ITALY
發行頻率四半期刊行
創刊年2008
每年文章數280每年文章數趨勢
黃金OA百分比99.89%
OA Related Info
APC: Yes( GBP2890; USD3990; EUR3390; )
APC waiver:Check Notes
Other charges: No
Keywords: oncology、cancer、human tumours
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ125/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-9966%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 66.66%
參考鏈接
相關期刊 【JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    CLINICAL CANCER RESEARCHH-index: 292

    CiteScore: 20.10
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS326092
    CANCER RESEARCH310905
    BMC CANCER242778
    INTERNATIONAL JOURNAL OF CANCER188166
    Asian Pacific Journal of Cancer Prevention184122
    CLINICAL CANCER RESEARCH180932
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY171552
    ONCOLOGY REPORTS171143
    CA-A CANCER JOURNAL FOR CLINICIANS163239
    CANCER148296
  •  

    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH] 的評論撰寫評論
作者: lsdjy


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-16 16:32:55 評論於
Hello, do I need to upload the original data when submitting a paper?
(0) 讚! | lsdjy

作者: brianyp


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2023-09-14 16:42:30 評論於
Requesting referees to provide feedback within 14 days, currently reviewing a manuscript
(1) 讚! | brianyp

作者: KEG


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-30 13:50:08 評論於
May I ask how long it took to receive the first revision comments?
(0) 讚! | KEG

作者: yang


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2022-07-02 18:20:07 評論於
The review process is fast, and the expert opinions are excellent. After making modifications according to the expert opinions, it is directly accepted for publication. It is a journal with extremely high cost-effectiveness.
(1) 讚! | yang

作者: 刘德华粉丝1303


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2018-12-23 18:28:55 評論於
Ten days after submission, I received the minor revision decision. I resubmitted it a day later. I was told that it will be in proofs in 10 days and online soon after. The journal has higher requirements for innovation and data. The acceptance rate is not high, about 10%. This year, the journal has significantly expanded. Last year, it published 189 articles, and nearly 300 this year.

(6) 讚! | 刘德华粉丝1303

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*